 Medifasts adjusted diluted EPS payout ratio will expand from just 38.8 in 2021 to a still manageable 51.6 in 2022. The company is admirably navigating a difficult environment, with revenue up 9.8 year to date and adjusted diluted EPS down 1.5 over the year-ago period. 